SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/41A5341C234A5CA0FD70444E414BEC4162AD7CD55C207A15A0F9C4BF14A3B8ED20D4B574C7F9DFC31C97A1634D5BE134>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/41A5341C234A5CA0FD70444E414BEC4162AD7CD55C207A15A0F9C4BF14A3B8ED20D4B574C7F9DFC31C97A1634D5BE134
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/41A5341C234A5CA0FD70444E414BEC4162AD7CD55C207A15A0F9C4BF14A3B8ED20D4B574C7F9DFC31C97A1634D5BE134
http://www.w3.org/2000/01/rdf-schema#comment
"The aptamer's potential for beta1(II)-AAB neutralization and consequently for cardiomyopathy treatment has been shown for the first time in vivo."
xsd:string
http://purl.uniprot.org/uniprot/#_5D6CBE77ED64BDA5070988BED6C5309B97D1D6BA5ADC7E177B5169DD731B61A8A3EB2EECDEBCB7665B4EBDE31CE33766
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/41A5341C234A5CA0FD70444E414BEC4162AD7CD55C207A15A0F9C4BF14A3B8ED20D4B574C7F9DFC31C97A1634D5BE134
http://purl.uniprot.org/uniprot/P18090
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/41A5341C234A5CA0FD70444E414BEC4162AD7CD55C207A15A0F9C4BF14A3B8ED20D4B574C7F9DFC31C97A1634D5BE134
http://purl.uniprot.org/uniprot/#_P18090-mappedCitation-24744110
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/41A5341C234A5CA0FD70444E414BEC4162AD7CD55C207A15A0F9C4BF14A3B8ED20D4B574C7F9DFC31C97A1634D5BE134